Per-name detailThe 10 companies, in depth
1. ZTS Zoetis Inc.
DEBATED
Drug Manufacturers - General · adj close 72.97 (div-adj)
Quality
92.8% pctile
Market doubt
1.00 / 1.00
News read — a real but unresolved debate — no clear damage yet: Down 41.9% YTD with no hard negatives mentioned; likely secular/competitive headwinds in animal health sector.. Lifts the opportunity score to 1.00 (from 0.92).
Business quality fingerprint
Returns
ROIC21.5% ▲
ROE80.2%
Gross profitability43.1% ▲
Margins
Gross margin70.5% ▲
Operating margin38.0% ▲
FCF margin24.1% (FCF+)
Growth (3-yr)
Revenue CAGR5.4%
EPS CAGR10.3%
Balance sheet
Net debt / EBITDA1.76
Share count (5-yr)-6.9%
Quality score0.81 · 92.8% pctile
What it does
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents.
Doubt & mispricing
The market doubts it (score 1.00): trading cheap versus its own multi-year range; down 53% from its 1-year high, below its 200-day line.
Recommended next step
BUY CANDIDATE — WORTH A CLOSE LOOK
Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -52.6% (skim recent headlines + the last earnings call).
Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.
Recent news
2. TTD The Trade Desk, Inc.
DEBATED
Advertising Agencies · adj close 13.40 (div-adj)
Quality
91.4% pctile
Market doubt
1.00 / 1.00
News read — a real but unresolved debate — no clear damage yet: HSBC downgrade cites competitive environment; no earnings miss or guidance cut mentioned. Secular competitive pressure.. Leaves the opportunity score about unchanged.
Business quality fingerprint
Returns
ROIC13.4% ▲
ROE17.8%
Gross profitability37.0% ▲
Margins
Gross margin78.6% ▼
Operating margin20.3% ▲
FCF margin27.5% (FCF+)
Growth (3-yr)
Revenue CAGR22.4%
EPS CAGR102.2%
Balance sheet
Net debt / EBITDA-0.29
Share count (5-yr)-3.2%
Quality score0.80 · 91.4% pctile
What it does
The Trade Desk, Inc. is a global technology company that provides a self-service, cloud-based platform. This platform enables advertising buyers to efficiently create, manage, and optimize data-driven digital ad campaigns across diverse formats and channels, including display, video, audio, native, and social media, reaching audiences on computers, mobile devices, and connected TVs. In addition to the platform, the company offers various data and value-added services.
Doubt & mispricing
The market doubts it (score 1.00): trading cheap versus its own multi-year range; down 76% from its 1-year high, below its 200-day line.
Recommended next step
BUY CANDIDATE — WORTH A CLOSE LOOK
Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -75.8% (skim recent headlines + the last earnings call).
Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.
Recent news
3. ROL Rollins, Inc.
DOUBT = SENTIMENT
Personal Products & Services · adj close 36.11 (div-adj)
Quality
88.0% pctile
Market doubt
0.97 / 1.00
News read — the doubt looks like sentiment, not damage: 38% YTD decline with mixed valuation signals; no hard negatives, earnings misses, or guidance cuts reported.. Lifts the opportunity score to 0.88 (from 0.84).
Business quality fingerprint
Returns
ROIC20.9% ▲
ROE38.3%
Gross profitability59.2% ▼
Margins
Gross margin49.4% ▼
Operating margin19.4% ▲
FCF margin17.3% (FCF+)
Growth (3-yr)
Revenue CAGR11.7%
EPS CAGR13.3%
Balance sheet
Net debt / EBITDA1.10
Share count (5-yr)-1.6%
Quality score0.77 · 88.0% pctile
What it does
Rollins, Inc. operates a network of subsidiaries that specialize in delivering pest and wildlife management solutions to a diverse clientele, encompassing both homeowners and commercial enterprises, throughout the United States and globally. For residential properties, the company offers comprehensive pest control, safeguarding homes from prevalent invaders such as rodents, insects, and other nuisance animals. Furthermore, it devises tailored pest management strategies for various business sectors, including healthcare, foodservice, and logistics.
Doubt & mispricing
The market doubts it (score 0.97): trading cheap versus its own multi-year range; down 45% from its 1-year high, below its 200-day line.
Recommended next step
BUY CANDIDATE — WORTH A CLOSE LOOK
Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -44.6% (skim recent headlines + the last earnings call).
Recent news
4. ISRG Intuitive Surgical, Inc.
NEWS CONSTRUCTIVE
Medical - Devices · adj close 390.33 (div-adj)
Quality
91.2% pctile
Market doubt
0.82 / 1.00
News read — the news is constructive: Earnings beat on both top and bottom line; revenue growth driven by procedure volumes and capex stability.. Lifts the opportunity score to 0.81 (from 0.74).
Business quality fingerprint
Returns
ROIC13.7% –
ROE16.0%
Gross profitability32.2% ▲
Margins
Gross margin66.0% ▼
Operating margin29.3% ▼
FCF margin24.7% (FCF+)
Growth (3-yr)
Revenue CAGR17.4%
EPS CAGR29.2%
Balance sheet
Net debt / EBITDA-0.77
Share count (5-yr)-0.8%
Quality score0.80 · 91.2% pctile
What it does
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach.
Doubt & mispricing
The market doubts it (score 0.82): trading cheap versus its own multi-year range; down 34% from its 1-year high, below its 200-day line.
Recommended next step
BUY CANDIDATE — WORTH A CLOSE LOOK
Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -34.2% (skim recent headlines + the last earnings call).
Notable: the balance sheet holds net cash, which de-risks the wait.
Recent news
5. APP AppLovin Corporation
DOUBT = SENTIMENT
Software - Application · adj close 311.98 (div-adj)
Quality
99.2% pctile
Market doubt
0.80 / 1.00
News read — the doubt looks like sentiment, not damage: Stock price pullback with analyst target trims but no earnings miss, guidance cut, or fundamental deterioration reported.. Lifts the opportunity score to 0.81 (from 0.79).
Business quality fingerprint
Returns
ROIC60.7% ▲
ROE156.2%
Gross profitability66.3% ▲
Margins
Gross margin87.9% ▲
Operating margin75.8% ▲
FCF margin71.9% (FCF+)
Growth (3-yr)
Revenue CAGR24.8%
EPS CAGR n/a
Balance sheet
Net debt / EBITDA0.24
Share count (5-yr)-0.2%
Quality score0.93 · 99.2% pctile
What it does
AppLovin Corporation provides a specialized software platform focused on empowering mobile application developers to enhance the marketing and revenue generation of their products. With operations spanning the United States and international markets, the company assists mobile app developers worldwide. Among its core software offerings is AppDiscovery, a marketing solution that intelligently connects advertiser demand with publisher supply through an auction-based model. Another key product is Adjust, an analytics platform that enables marketers to scale their mobile apps by offering…
Doubt & mispricing
The market doubts it (score 0.80): down 57% from its 1-year high, below its 200-day line.
Recommended next step
BUY CANDIDATE — WORTH A CLOSE LOOK
Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -57.5% (skim recent headlines + the last earnings call).
Notable: still growing fast (rev CAGR 24.8%) despite the doubt.
Recent news
6. CPRT Copart, Inc.
DOUBT = SENTIMENT
Specialty Business Services · adj close 31.70 (div-adj)
Quality
90.8% pctile
Market doubt
0.76 / 1.00
News read — the doubt looks like sentiment, not damage: Price weakness vs. market with no fundamental catalyst, earnings miss, guidance cut, or hard negative news.. Lifts the opportunity score to 0.81 (from 0.77).
Business quality fingerprint
Returns
ROIC14.7% ▼
ROE16.9%
Gross profitability20.8% ▼
Margins
Gross margin45.2% ▼
Operating margin36.5% ▼
FCF margin26.5% (FCF+)
Growth (3-yr)
Revenue CAGR9.9%
EPS CAGR12.1%
Balance sheet
Net debt / EBITDA-1.27
Share count (5-yr)+1.7%
Quality score0.79 · 90.8% pctile
What it does
Copart, Inc. stands as a prominent global provider of online vehicle auctions and comprehensive vehicle remarketing services. The company extends its operations across numerous international markets, including the United States, the United Kingdom, Germany, Brazil, Canada, the United Arab Emirates, Spain, Finland, Oman, the Republic of Ireland, and Bahrain. At its core, Copart enables the buying and selling of vehicles over the internet through its sophisticated "virtual bidding" online auction platform.
Doubt & mispricing
The market doubts it (score 0.76): trading cheap versus its own multi-year range; down 37% from its 1-year high, below its 200-day line.
Recommended next step
BUY CANDIDATE — WORTH A CLOSE LOOK
Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -36.6% (skim recent headlines + the last earnings call).
Notable: the balance sheet holds net cash, which de-risks the wait.
Recent news
7. ADBE Adobe Inc.
DOUBT = SENTIMENT
Software - Application · adj close 254.04 (div-adj)
Quality
97.4% pctile
Market doubt
0.79 / 1.00
News read — the doubt looks like sentiment, not damage: Price action, options volatility, and analyst commentary with no hard negatives or fundamental catalysts.. Lifts the opportunity score to 0.78 (from 0.69).
Business quality fingerprint
Returns
ROIC36.7% ▲
ROE61.3%
Gross profitability71.4% ▲
Margins
Gross margin88.6% –
Operating margin36.6% –
FCF margin41.4% (FCF+)
Growth (3-yr)
Revenue CAGR10.5%
EPS CAGR18.2%
Balance sheet
Net debt / EBITDA0.12
Share count (5-yr)-11.2%
Quality score0.88 · 97.4% pctile
What it does
Adobe Inc. stands as a prominent global software provider, delivering a diverse range of solutions. Its operations are structured into three primary business divisions: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment empowers individuals, teams, and enterprises to generate, disseminate, and amplify various forms of content through its array of products and services, including the cloud-native Document Cloud platform.
Doubt & mispricing
The market doubts it (score 0.79): trading cheap versus its own multi-year range; down 31% from its 1-year high, below its 200-day line. Early signs of a turn in margins or returns.
Recommended next step
HOLD OFF — CONFIRM THE TURN
The ROIC/margin upturn is only a period or two old. Wait for the next earnings report to confirm it's a trend (not one print), and watch for upward analyst estimate revisions before acting.
Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.
Recent news
8. LULU Lululemon Athletica Inc.
DEBATED
Apparel - Retail · adj close 115.74 (div-adj)
Quality
87.2% pctile
Market doubt
0.94 / 1.00
News read — a real but unresolved debate — no clear damage yet: New CEO appointment signals reset needed; structural challenges unresolved but no realized earnings miss or demand decline yet.. Lifts the opportunity score to 0.78 (from 0.74).
Business quality fingerprint
Returns
ROIC22.7% ▼
ROE31.8%
Gross profitability74.3% ▲
Margins
Gross margin56.6% ▼
Operating margin19.9% ▼
FCF margin8.3% (FCF+)
Growth (3-yr)
Revenue CAGR11.0%
EPS CAGR25.7%
Balance sheet
Net debt / EBITDA-0.00
Share count (5-yr)-8.6%
Quality score0.76 · 87.2% pctile
What it does
Lululemon Athletica Inc., alongside its subsidiaries, specializes in the design, global distribution, and retail of athletic apparel and accessories for both women and men. Its business operations are structured into two main divisions: company-owned retail establishments and direct-to-consumer sales. The firm's offerings encompass a range of clothing such as pants, shorts, tops, and jackets, all crafted for promoting a healthy lifestyle and facilitating athletic endeavors. These activities span yoga, running, training, and other physically demanding pursuits.
Doubt & mispricing
The market doubts it (score 0.94): trading cheap versus its own multi-year range; down 46% from its 1-year high, below its 200-day line.
Recommended next step
BUY CANDIDATE — WORTH A CLOSE LOOK
Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -46.4% (skim recent headlines + the last earnings call).
Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.
Recent news
9. RMD ResMed Inc.
NEWS CONSTRUCTIVE
Medical - Devices · adj close 220.37 (div-adj)
Quality
97.2% pctile
Market doubt
0.64 / 1.00
News read — the news is constructive: Q4 earnings beat with 16% YoY EPS growth and revenue rise; stock down despite beat suggests unearned doubt.. Lifts the opportunity score to 0.71 (from 0.63).
Business quality fingerprint
Returns
ROIC19.6% ▲
ROE23.5%
Gross profitability37.4% ▼
Margins
Gross margin59.4% ▲
Operating margin32.7% ▲
FCF margin32.3% (FCF+)
Growth (3-yr)
Revenue CAGR12.9%
EPS CAGR21.5%
Balance sheet
Net debt / EBITDA-0.19
Share count (5-yr)+0.6%
Quality score0.88 · 97.2% pctile
What it does
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices.
Doubt & mispricing
The market doubts it (score 0.64): trading cheap versus its own multi-year range; down 24% from its 1-year high, below its 200-day line.
Recommended next step
BUY CANDIDATE — WORTH A CLOSE LOOK
Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -24.4% (skim recent headlines + the last earnings call).
Notable: the balance sheet holds net cash, which de-risks the wait.
Recent news
10. AOS A. O. Smith Corporation
DOUBT = SENTIMENT
Industrial - Machinery · adj close 61.40 (div-adj)
Quality
89.8% pctile
Market doubt
0.76 / 1.00
News read — the doubt looks like sentiment, not damage: Institutional buying, quality metrics affirmed, no fundamental deterioration or hard negatives reported.. Lifts the opportunity score to 0.70 (from 0.66).
Business quality fingerprint
Returns
ROIC23.9% ▲
ROE29.4%
Gross profitability47.3% ▲
Margins
Gross margin38.8% ▲
Operating margin19.0% ▲
FCF margin14.3% (FCF+)
Growth (3-yr)
Revenue CAGR0.7%
EPS CAGR36.7%
Balance sheet
Net debt / EBITDA0.02
Share count (5-yr)-13.3%
Quality score0.79 · 89.8% pctile
What it does
A. O. Smith Corporation (AOS) is a global manufacturer and marketer specializing in a comprehensive array of water heating and treatment solutions. Its operations span North America, China, Europe, and India, organized into two primary geographic segments: North America and Rest of World.
Doubt & mispricing
The market doubts it (score 0.76): trading cheap versus its own multi-year range; down 23% from its 1-year high, below its 200-day line. Early signs of a turn in margins or returns.
Recommended next step
HOLD OFF — CONFIRM THE TURN
The ROIC/margin upturn is only a period or two old. Wait for the next earnings report to confirm it's a trend (not one print), and watch for upward analyst estimate revisions before acting.
Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.
Recent news